Leading the way to improve the lives of patients with type 1 diabetes
The Elizabeth Weiser Caswell Diabetes Institute, in partnership with Breakthrough T1D (formerly JDRF), is using team science to pursue type 1 diabetes (T1D) cures and reduce disease burden through improved treatments
Watch
Our research advances knowledge, translating into
better care and patient perspectives
Our team science approach in action
Our projects are aligned with a patient-centered focus to understand and modulate the metobolic environment of beta cells to improve T1D patient outcomes. Our projects connect data from multiple disciplines via a common data portal to inform research across projects.
*Metabotype respresents the integrative metabolic profile of an individual.
Who We Are
Leadership
Tom Gardner, MD, MS
Matthias Kretzler, MD
Scott Soleimanpour, MD
Lonnie Shea, PhD
Rodica Pop-Busui, MD, PhD
Subramaniam Pennathur, MD
